140 likes | 294 Views
Effects of biotin on pyruvate carboxylase, acetyl CoA carboxylase, propionyl CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Lisolet Avila Sarah Tobin . Biotin. Decreased biotin status is observed in: Pregnancy
E N D
Effects of biotin on pyruvate carboxylase, acetyl CoA carboxylase, propionyl CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Lisolet Avila Sarah Tobin
Biotin • Decreased biotin status is observed in: • Pregnancy • Elderly • Athletes • Type 2 Diabetics • Assessment of biotin status • 3-hydroxyisovaleric acid • Propionyl CoA Carboxylase (PCC) • Sensitive indicator of biotin status
Biotin and PCC, PC, and ACC Acetyl CoA Carboxylase (ACC) Pyruvate Carboxylase (PC) Propionyl-CoA Carboxylase (PCC)
Purpose • To determine the biotin effects on the carboxylase activities, and the plasma metabolites in type 2 diabetic and nondiabetic subjects.
Methods • Mexican study • Subjects: 39 patients (20 women, 19 men) of type 2 DM, aged 33-70 years old • Control group: 42 nondiabetic subjects (29 women,13 men), aged 30-60 years old • Two protocols • Venous blood samples after an overnight 12 h fast • On days 0, 14 and 28. • Double blind placebo control study • Either placebo or 20.5 µmol biotin 3 times/day =15mg
Results • Carboxylase activities at baseline • No difference between diabetic and nondiabetic subjects. • No significant correlation between fasting glucose concentrations and the activities of PCC, AC and ACC.
Results • Effect of biotin administration on carboxylases • Increased enzymatic activity in all the carboxylases after administration of 61.4 µmol/d for 28 days.
Results • Effect of biotin administration on plasma metabolites • Biotin treatment showed not effect on fasting glucose, insulin, triacylglycerols, cholesterol or lactate concentrations. • Both diabetic and nondiabetic subjects showed same results. • Placebo did not alter any result.
Author’s conclusions No direct correlation between PCC activity and fasting glucose concentrations PC and ACC activity did not differ significantly between diabetic and nondiabetic subjects. Biotin treatment increases PCC activity in both malnourished and subject with no nutrition deficiencies. PC and ACC activity increases with biotin treatment. PC activity was more sensitive to biotin supplementation that PCC and ACC.
Our Thoughts… • Limitations • Genetic and nutritional differences between Mexican and other populations. • Japanese study showed much different results. • Cross-sectional study is needed. • Diet Regulation
Our Thoughts… Expected Results: • Biotin increases PCC, PC, and ACC activity • This is expected because biotin is a cofactor Unexpected Results • PC and ACC activity: same in diabetic and nondiabetic? • Diabetic patients have been shown to have a lower serum biotin concentration than control groups. With biotin treatment, diabetic subjects should have a higher activity? • Biotin treatment increases PCC in subjects who are malnourished as well as those with no nutritional deficiencies • Increased enzymatic activity, even in those with a sufficient diet
More Thoughts… • PC activity more sensitive to biotin than PCC and ACC • This result is different than other studies which have shown that PCC activity is a sensitive indicator of serum biotin concentration. • PCC Activity and fasting glucose concentrations • Carboxylase and glucose concentrations = no correlation • Past studies have shown that biotin induces insulin secretion, glucokinase, and downregulates PEPCK expression in biotin deficient rats.
Question! What are the possible metabolic outcomes observed in biotin deficient individuals? Hint: Outcome from PC, ACC, PCC and MCC Answer: Lactic Acidosis, Ketosis, Accumulation of Metabolites: ie. 3-hydroxyisovaleric
Reference 1)Baez-Saldana A, Cardenas A, Fernandez-Mejia C, Islas-Andrade S, Revilla-Monsalve C, Rojas-Ochoa A and Zendejas-Ruiz I. Effects of biotin on pyruvatecarboxylase, acetyl CoAcarboxylase, propionyl-CoAcarboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. 2004 American Journal of Clinical Nutrition. 2004; 79:238-243.